Home › Trial NCT07021261
Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients
- Trial IDNCT07021261
- StatusNot Yet Recruiting
- PhasePhase 3
- Study typeInterventional
- SponsorFudan University
- Enrollment440
- Start date2025-06-16
- ConditionsBreast Cancer · TNBC
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.